Literature DB >> 15151960

Intratumoral injection of herpes simplex virus HF10 in recurrent breast cancer.

A Nakao, H Kimata, T Imai, T Kikumori, O Teshigahara, T Nagasaka, F Goshima, Y Nishiyama.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15151960     DOI： 10.1093/annonc/mdh225

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  22 in total

Review 1.  Intratumoral Immunotherapy-Update 2019.

Authors:  Omid Hamid; Rubina Ismail; Igor Puzanov
Journal:  Oncologist       Date:  2019-11-29

Review 2.  Employing tumor hypoxia for oncolytic therapy in breast cancer.

Authors:  Yun Shin Chun; Prasad S Adusumilli; Yuman Fong
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

3.  Gene therapy for pain: results of a phase I clinical trial.

Authors:  David J Fink; James Wechuck; Marina Mata; Joseph C Glorioso; James Goss; David Krisky; Darren Wolfe
Journal:  Ann Neurol       Date:  2011-07-27       Impact factor: 10.422

4.  The efficacy of combination therapy with oncolytic herpes simplex virus HF10 and dacarbazine in a mouse melanoma model.

Authors:  Rui Tanaka; Fumi Goshima; Shinichi Esaki; Yoshitaka Sato; Takayuki Murata; Yukihiro Nishiyama; Daisuke Watanabe; Hiroshi Kimura
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

Review 5.  A human trial of HSV-mediated gene transfer for the treatment of chronic pain.

Authors:  D Wolfe; M Mata; D J Fink
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

6.  Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer.

Authors:  S Fujiwara; A Nawa; C Luo; M Kamakura; F Goshima; C Kondo; T Kiyono; F Kikkawa; Y Nishiyama
Journal:  Cancer Gene Ther       Date:  2010-10-01       Impact factor: 5.987

7.  A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma.

Authors:  Hiroo Takaoka; Gen Takahashi; Fumi Ogawa; Tomoaki Imai; Soichi Iwai; Yoshiaki Yura
Journal:  Virol J       Date:  2011-06-10       Impact factor: 4.099

Review 8.  Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data.

Authors:  Dmitriy Zamarin; Sari Pesonen
Journal:  Hum Gene Ther       Date:  2015-08       Impact factor: 5.695

9.  Systemic CD8+ T cell-mediated tumoricidal effects by intratumoral treatment of oncolytic herpes simplex virus with the agonistic monoclonal antibody for murine glucocorticoid-induced tumor necrosis factor receptor.

Authors:  Mikiya Ishihara; Naohiro Seo; Jun Mitsui; Daisuke Muraoka; Maki Tanaka; Junichi Mineno; Hiroaki Ikeda; Hiroshi Shiku
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

Review 10.  Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs.

Authors:  Lynne Braidwood; Sheila V Graham; Alex Graham; Joe Conner
Journal:  Oncolytic Virother       Date:  2013-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.